logo
logo
Sign in

Mosquito Repellents Segment is Fastest Growing Fueling Growth of Mosquito Borne Disease Market

avatar
naufan003
Mosquito Repellents Segment is Fastest Growing Fueling Growth of Mosquito Borne Disease Market

The global Mosquito Borne Disease Market is estimated to be valued at US$ 3.11 Bn in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Mosquito borne diseases affect millions of people worldwide every year. With the changing environment, people are increasingly facing risk of vector borne diseases like dengue, malaria, chikungunya and yellow fever. The need for effective prevention in the form of mosquito repellents is driving significant growth of this market segment.

Market Overview:

The mosquito borne disease market comprises of products indicated for prevention, diagnosis and treatment of diseases spread by the bite of an infected mosquito. These diseases include malaria, dengue, chikungunya, yellow fever, Zika virus and others. Advancements in vector control strategies, integrated disease surveillance and prompt diagnosis & management have provided effective control over these diseases.

Market key trends:

One of the key trends in this market is growing demand for advanced mosquito repellent products. With rising health concerns, consumers are increasingly opting for novel formulations that provide long lasting protection. Manufacturers are investing in development of app-based repellents, wearables and smart city products for mosquito surveillance and population control. Novel active ingredients, slow releasing formulations and synergistic blends are also gaining popularity. This is expected to drive new product premiumization as well as support overall market revenue growth in the forecast period.

Segment Analysis

The global mosquito borne disease market is dominated by the malaria segment. Malaria accounts for over 90% of the total market share owing to the high prevalence of malaria parasites such as Plasmodium falciparum and Plasmodium vivax in tropical and subtropical regions. Malaria remains one of the most life-threatening mosquito borne diseases, causing significant mortality and draining healthcare resources in endemic countries.

Key Takeaways

The Global Mosquito Borne Disease Market Size is expected to witness high growth, exhibiting CAGR of 7.3% over the forecast period, due to increasing research efforts towards developing innovative treatments and vaccines.

Regional analysis

Asia Pacific dominates the global mosquito borne disease market and is expected to maintain its leading position during the forecast period. This can be attributed to the high burden of malaria, dengue, chikungunya, Japanese encephalitis, and other diseases in the region. Countries such as India, Indonesia, Pakistan, and Bangladesh have the highest malaria incidence in the world.

Key players

Key players operating in the mosquito borne disease market are GlaxoSmithKline plc, Sanofi S.A., Pfizer Inc., Merck & Co. Inc., Novartis AG, Johnson & Johnson, Eisai Co. Ltd, Takeda Pharmaceuticals, AstraZeneca, Valeant Pharmaceuticals, Mitsubishi Tanabe Pharma, Abbott, F. Hoffmann-La Roche Ltd, Sun Pharmaceutical Industries Ltd, Lupin Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Serum Institute of India Pvt. Ltd., CSL Limited, Teva Pharmaceutical Industries Ltd.


Read more: https://www.ukwebwire.com/mosquito-borne-disease-market-insights-trends/

collect
0
avatar
naufan003
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more